Memphis Pharmaceuticals & Chemical Industries (CASE: MPCI)
Health Care · Pharmaceuticals · EG
EGP375.63
-1.41% today · +181.4% 1Y
Memphis Pharmaceuticals & Chemical Industries (CASE: MPCI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $167.96M.
Over the last twelve months the share price has gained 181.4%, trading between 127.00 and 460.20.
Tweenvest scores Memphis Pharmaceuticals & Chemical Industries across four factors: quality 77/100, value 41/100, growth 82/100, dividend 90/100. Its strongest factor is dividend.
MPCI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $167.96M
- Revenue (TTM)
- $35.12M
- P/E
- 16.47
- EPS
- 22.81
- Dividend yield
- 3.51%
- Beta (5Y)
- 0.11
- 52-week high
- EGP460.20
- 52-week low
- EGP127.00
- Avg volume (3M)
- —
- Shares outstanding
- 22.75M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.